Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-12-23 5:26 pm Purchase | 13D | Aadi Bioscience, Inc. AADI | Neil Desai | 2,263,566 9.200% | 145,961 (+6.89%) | View |
2024-12-23 3:51 pm Purchase | 13D | Aadi Bioscience, Inc. AADI | Scott Epstein | 3,581,961 14.500% | 110,209 (+3.17%) | View |
2024-10-01 5:35 pm Sale | 13D | Aadi Bioscience, Inc. AADI | Neil Desai | 2,117,605 8.500% | -517,591 (-19.64%) | View |
2024-09-03 5:51 pm Purchase | 13G | Aadi Bioscience, Inc. AADI | EcoR1 Capital LLC | 1,845,253 7.500% | 1,845,253 (New Position) | View |
2024-08-28 4:42 pm Purchase | 13G | Aadi Bioscience, Inc. AADI | BML Investment Partners L.P. | 1,383,817 5.600% | 1,383,817 (New Position) | View |
2023-02-13 5:39 pm Sale | 13G | Aadi Bioscience, Inc. AADI | Vivo Panda LLC | 509,572 2.100% | -218,095 (-29.97%) | View |
2023-02-10 1:04 pm Purchase | 13G | Aadi Bioscience, Inc. AADI | Satter Muneer A | 1,630,830 6.700% | 336,045 (+25.95%) | View |
2023-01-17 4:59 pm Purchase | 13D | Aadi Bioscience, Inc. AADI | Neil Desai | 2,635,196 10.800% | 36,755 (+1.41%) | View |
2022-10-04 4:01 pm Purchase | 13G | Aadi Bioscience, Inc. AADI | Satter Muneer A | 1,294,785 5.300% | 1,294,785 (New Position) | View |
2022-09-26 5:27 pm Purchase | 13D | Aadi Bioscience, Inc. AADI | Scott Epstein | 3,471,752 14.400% | 1,260,000 (+56.97%) | View |
2022-02-14 4:13 pm Purchase | 13G | Aadi Bioscience, Inc. AADI | Venrock Healthcare Capital Partners II L.P. | 1,529,402 7.300% | 1,529,402 (New Position) | View |
2022-02-11 7:33 pm Sale | 13G | Aadi Bioscience, Inc. AADI | BIOTECHNOLOGY VALUE FUND L P | 899,392 4.300% | -247,660 (-21.59%) | View |
2022-02-11 5:20 pm Sale | 13G | Aadi Bioscience, Inc. AADI | Vivo Panda LLC | 727,667 3.500% | -113,504 (-13.49%) | View |
2022-02-09 3:15 pm Purchase | 13G | Aadi Bioscience, Inc. AADI | VANGUARD GROUP INC | 761,473 3.640% | 761,473 (New Position) | View |
2021-11-15 4:33 pm Sale | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA CAPITAL MANAGEMENT LLC | 0 0.000% | -165,749 (Position Closed) | View |
2021-11-12 4:03 pm Sale | 13D | Aadi Bioscience, Inc. AADI | Satter Muneer A | 374,785 1.790% | -4 (-0.00%) | View |
2021-09-08 5:30 pm Purchase | 13D | Aadi Bioscience, Inc. AADI | Neil Desai | 2,598,441 12.400% | 2,598,441 (New Position) | View |
2021-09-07 5:26 pm Purchase | 13G | Aadi Bioscience, Inc. AADI | BIOTECHNOLOGY VALUE FUND L P | 1,147,052 5.500% | 1,147,052 (New Position) | View |
2021-09-07 5:25 pm Purchase | 13D | Aadi Bioscience, Inc. AADI | ACUTA CAPITAL PARTNERS LLC | 1,548,081 7.300% | 1,548,081 (New Position) | View |
2021-09-03 4:47 pm Sale | 13D | Aadi Bioscience, Inc. AADI | ORBIMED ADVISORS LLC | 346,262 1.700% | -1 (-0.00%) | View |